Achieve Life Sciences (ACHV) Treasury Shares (2012 - 2026)
Achieve Life Sciences' (ACHV) quarterly Treasury Shares came in at $1.1 million in Q1 2026, down 60.66% YoY from $2.8 million in Q1 2025, and little changed on a QoQ basis from $1.1 million in Q4 2025.
Achieve Life Sciences (ACHV) Treasury Shares (2012 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 15 years of Treasury Shares data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Treasury Shares fell 60.66% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 60.66% YoY) and the FY2025 annual result came in at $1.1 million, down 15.53% from the prior year.
- Treasury Shares was little changed at $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2025 to a low of $252875.0 in Q2 2022.
- A 5-year average of $1.0 million and a median of $1.1 million in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares jumped 374.88% — and 2026, when it plunged 60.66%.
- Tracing ACHV's Treasury Shares over 5 years: stood at $252875.0 in 2022, then soared by 100.84% to $507875.0 in 2023, then jumped by 152.77% to $1.3 million in 2024, then retreated by 15.53% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
- The last three Treasury Shares figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 14.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.48 Mn |
| Jun 30, 2026 | 14.48 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |